-
The pharmaceutical company announced that its experimental pill reduced hospitalizations and deaths by half in people infected with the coronavirus. The findings are not peer reviewed.
-
At least three promising antiviral treatments for COVID-19 are being tested in clinical trials, with results expected as soon as late fall or winter.
-
Merck traditionally has been a leader in vaccines but has not had success with a COVID-19 vaccine. It's lending a hand to Johnson & Johnson, where production is running significantly behind schedule.